The AMPLITUDE study is looking for men with newly diagnosed metastatic prostate cancer.
Am I eligible?
You may be able to participate in the AMPLITUDE study if you:
• Are 18 years of age or older
• Have been recently diagnosed with metastatic prostate cancer, which means that cancer
has spread to other parts of the body such as bones, liver, or lung
• Willing to be tested or have already a positive test by blood, tissue, or saliva sample for
specific genetic alterations
If you want to learn more about genetic alterations or biomarkers, please watch this video:
https://content.gtc-api.dev/sites/default/files/2020-08/GTC_OnlineEngagement-
ENG09_Biomarkers_V1.0_040220_Final.mp4
Study design
The AMPLITUDE study is looking at the effectiveness and safety of an investigational combination of
medications compared with a standard prostate cancer therapy. The study is double-blind which
means neither you nor your study doctor will know which medication you will be receiving during
the trial.
Interested in participating?
To learn more about this study, if you may be eligible and if the study is being conducted at a site
near you, please visit: https://clinicaltrials.gov/ct2/show/NCT04497844?recrs=b&cond=niraparib&draw=3&rank=15
or https://globaltrialfinder.janssen.com/
Please Note: This information is provided for education and awareness purposes. A decision on clinical trial participation is to be made between the patient and his doctor.